Mr Yousef Ijjeh
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
I am a doctoral student and graduate researcher at the South Australian ImmunoGenomics Cancer Institute within Adelaide University, operating under the principal supervision of Dr. Zeyad D. Nassar. With an academic background that includes a Pharm.D. from the Jordan University of Science and Technology and a master's degree in biomedical engineering with a specialization in molecular and cellular biotherapies from Paris Descartes University, my research centers on oncology, nanomedicine, and molecular biology, particularly investigating tumor microenvironments and advanced therapeutic delivery systems. Currently, I am studying fatty acid oxidation (FAO) in prostate cancer and working to investigate the effects of histone acetyltransferase inhibitors (HATi) and fatty acid oxidation inhibitors (FOAi) in this malignancy. My scholarly contributions include peer-reviewed publications exploring targeted drug delivery, metabolic stress in cancer cell lines, digital design applications for sustainable nanomedicine, and aptamer-guided CRISPR delivery systems.
I am a doctoral student and graduate researcher at the South Australian ImmunoGenomics Cancer Institute within Adelaide University, operating under the principal supervision of Dr. Zeyad D. Nassar. My current doctoral research centers on oncology and molecular metabolism, where I am actively studying fatty acid oxidation (FAO) in prostate cancer and investigating the therapeutic potential and mechanistic impact of histone acetyltransferase inhibitors (HATi) and fatty acid oxidation inhibitors (FOAi) within this malignancy.
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2019 - 2020 | Délégation Paris 5 | France | MSc |
| Jordan University of Science and Technology | Jordan | BSc |
| Year | Citation |
|---|---|
| 2026 | Saleh, M. M., Alsarayreh, N., Aladaileh, N., Ijjeh, Y., Alqudah, D. A., Al-Zain, H., . . . Alshaer, W. (2026). Design of liposomal tocopherol phosphate for dermal applications.. International journal of pharmaceutics, 690, 126571. |
| 2026 | Albatsh, M., Ijjeh, Y., Alsarayreh, N., Alqudah, D. A., & Alshaer, W. (2026). Cabazitaxel and camptothecin co-loaded in pH-sensitive transferrin-targeted, PEGylated cholesterol-based poly(amidoamine) dendrimers as a synergistic combination for prostate cancer.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 202, 119794. |
| 2026 | Ijjeh, Y., Alsarayreh, N., Alqudah, D., Elzogheir, N., Abuhaliema, A., Shomali, M. R., . . . Alshaer, W. (2026). Aptamer‐Guided CRISPR Systems Delivery: Precision Targeting Strategies, Translational Barriers, and Therapeutic Potential. Advanced Therapeutics, 9(3). |
| 2025 | Ijjeh, Y., Alsarayreh, N., Rifai, A., Abdelnabi, H., Al-Mahamid, S., Alqudah, D. A., . . . Alshaer, W. (2025). Quality by digital design for accelerated sustainable nanomedicine development.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 213, 107239. Europe PMC8 |
| 2025 | Alshaer, W., Ijjeh, Y., Alsarayreh, N., Alqudah, D. A., Rifai, A., Abu-Siniyeh, A., & Alsalem, M. (2025). Combined Effects of Atorvastatin and Glucose Deprivation on Metabolic Stress and Lipid-Raft Disruption in Glioblastoma and Breast Cancer Cells.. Pharmaceutics, 17(10), 1275. |
| 2023 | Rittavee, Y., Artus, J., Desterke, C., Simanic, I., de Souza, L. E. B., Riccaldi, S., . . . Foudi, A. (2023). miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells.. Experimental hematology, 118, 40-52. Europe PMC9 |
| 2023 | Artus, J., Zenych, A., Simanic, I., Desterke, C., Clay, D., Saïm, S., . . . Foudi, A. (2023). BCR-ABL promotes hematopoietic stem and progenitor cell formation in embryonic stem cells.. Experimental hematology, 124, 22-35.e3. Europe PMC3 |
| - | Alsarayreh, N., Ijjeh, Y., AbuSaifan, H., AlQuaissi, B., Elzogheir, N., Alqudah, D., . . . Alshaer, W. (2026). Aptamer guided nanomedicines enable precision immune engineering. Discover Applied Sciences, 8(4). |
Connect With Me
External Profiles
